ATI RN
FNP Pediatric Practice Questions Questions
Question 1 of 5
The parent of a child with glomerulonephritis asks how they will know the child is improving. Which is the best response?
Correct Answer: A
Rationale: An increase in urine output and a return to normal urine color are clear, observable signs of improvement in glomerulonephritis.
Question 2 of 5
Clients with myastherda gravis, Guillain - Barre Syndrome or amyothrophic sclerosis experience:
Correct Answer: C
Rationale: Clients with myasthenia gravis, Guillain-Barre Syndrome, or amyotrophic lateral sclerosis (ALS) are all affected by various neuromuscular conditions that can lead to respiratory complications. These conditions can cause weakness in the muscles involved in breathing, leading to difficulties with coughing, clearing secretions, and maintaining adequate ventilation. This weakness can ultimately result in an increased risk of breathing difficulties, respiratory infections, and respiratory failure. Therefore, clients with these conditions require close monitoring and respiratory support to manage and prevent complications related to respiratory function.
Question 3 of 5
The major pharmacologic action of albuterol sulfate (Proventil HFA) is:
Correct Answer: D
Rationale: Albuterol acts as a beta-2 agonist, relaxing bronchial smooth muscle to relieve airway constriction.
Question 4 of 5
A child is brought to your clinic for a routine exam. She can dress with help, can ride a tricycle, knows her own age, and can speak in short sentences. She had difficulty in copying a square. The age of this child is most likely:
Correct Answer: C
Rationale: At 3 years, children typically have the ability to dress with assistance, ride a tricycle, know their age, and speak in short sentences. Copying a square usually occurs later, around 4 years of age.
Question 5 of 5
When caring for the child with Kawasaki disease, the nurse should know which information?
Correct Answer: D
Rationale: Kawasaki disease is an acute febrile illness that primarily affects children. The therapeutic management of Kawasaki disease includes the administration of gamma globulin and aspirin. Intravenous immunoglobulin (IVIG) or gamma globulin is given as a single dose to reduce the risk of coronary artery abnormalities, while aspirin is used for its anti-inflammatory effects. It is important to note that aspirin should not be given to children with viral infections due to the risk of Reye syndrome. Therefore, option D is the correct choice in this case.